Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LBPH | Voting Common Stock | Sale | -$96.5M | -3.98M | -100% | $24.25* | 0 | Jan 25, 2024 | Direct | F1 |
Arena Pharmaceuticals Inc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | The per share price is reported before fees. |